TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Asahi Kasei Bioprocess

Profile

Asahi Kasei Bioprocess manufactures capital equipment to accommodate the increasing number of antisense oligonucleotides and RNAi-based drugs entering Phase II or Phase III clinical trials. By pairing Asahi Oligosynthesizers and Synthesis Columns with Cleavage and Deprotection Systems, process engineers can increase throughput and drive down costs during the synthesis process. In addition, MPLC and HPLC columns and systems feature minimized system hold-up along with sanitary or hygienic flow paths optimized for ion exchange purification of oligonucleotides and higher backpressures. Please visit at Stand 47 for more information.


Contact


Thomas Krebstakies

Thomas.krebstakies@ak-bio.com

Contact